This systematic review investigated whether the insulin sensitiser metformin has a
geroprotective effect in humans. Pubmed and Embase were searched along with databases …

Background Diabetes and elevated blood glucose have been associated with increased risk
of atrial fibrillation in a number of epidemiological studies, however, the findings have not …

Chronic heart failure (HF) and diabetes mellitus (DM) commonly coexist. Each condition
increases the likelihood of developing the other, and when they occur together in the same …

ContextThiazolidinediones (TZDs), used to treat type 2 diabetes, are associated with an
excess risk of congestive heart failure and possibly acute myocardial infarction. However …

OBJECTIVE—Thiazolidinediones (TZDs) are known to increase the risk of heart failure in
patients with type 2 diabetes. We aimed to evaluate the magnitude of the risk of heart failure …

OBJECTIVE—Impaired glucose tolerance (IGT) and/or impaired fasting glucose (IFG) are
risk factors for diabetes, cardiovascular disease (CVD), and kidney disease. We determined …

Thiazolidinedione (TZD) drugs used in the treatment of type 2 diabetes mellitus (T2DM)
have proven effective in improving insulin sensitivity, hyperglycemia, and lipid metabolism …

Judicious prescribing is a prerequisite for safe and appropriate medication use. Based on
evidence and lessons from recent studies demonstrating problems with widely prescribed …

OBJECTIVE To examine, among patients with type 2 diabetes, the association between
hospitalization for heart failure (hHF) and treatment with dipeptidyl peptidase 4 inhibitors …

Diabetes mellitus and heart failure (HF), both of which are associated with high rates of
adverse cardiovascular outcomes, commonly coexist. Given the marked increases in …